EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Delayed definitive management of localized prostate cancer: what do we know?

Osama Mohamad, Yun Rose Li, Felix Feng, Julian C Hong, Anthony Wong, Zakaria El Kouzi, Mohamed Shelan, Thomas Zilli, Peter Carroll, Mack Roach

Prostate Cancer and Prostatic Diseases · 2025

DOI: 10.1038/s41391-024-00876-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Prostate Cancer and Prostatic Diseases, 2025. Verfasst von Osama Mohamad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genito-urinary Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, COVID-19, Time-to-Treatment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delays in the work-up and definitive management of patients with prostate cancer are common, with logistics of additional work-up after initial prostate biopsy, specialist referrals, and psychological reasons being the most common causes of delays. During the COVID-19 pandemic and the subsequent surges, timing of definitive care delivery with surgery or radiotherapy has become a topic of significant concern for patients with prostate cancer and their providers alike. In response, recommendations for the timing of definitive management of prostate cancer with radiotherapy and radical prostatectomy were published but without a detailed rationale for these recommendations. While the COVID-19 pandemic is behind us, patients are always asking the question: “When should I start radiation or undergo surgery?” In the absence of level I evidence specifically addressing this question, we will hereby present a narrative review to summarize the available data on the effect of treatment delays on oncologic outcomes for patients with localized prostate cancer from prospective and retrospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCOVID-19Time-to-TreatmentHumansMaleSARS-CoV-2ProstatectomyDisease Management

Autor:innen und Institutionen

  • Department of Genito-urinary Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Radiation Oncology, City of Hope Cancer center, Duarte, CA, USA.
  • Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Department of Urology, University of California San Francisco, San Francisco, CA, USA.
  • Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.

Zitieren

APA

Mohamad, O., Li, Y. R., Feng, F., Hong, J. C., Wong, A., El Kouzi, Z., Shelan, M., Zilli, T., Carroll, P., & Roach, M. (2025). Delayed definitive management of localized prostate cancer: what do we know?. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-024-00876-2

Vancouver

Mohamad O, Li YR, Feng F, Hong JC, Wong A, El Kouzi Z, et al. Delayed definitive management of localized prostate cancer: what do we know?. Prostate Cancer and Prostatic Diseases. 2025. doi:10.1038/s41391-024-00876-2

BibTeX
@article{Mohamad2025,
  author = {Mohamad, Osama and Li, Yun Rose and Feng, Felix and Hong, Julian C and Wong, Anthony and El Kouzi, Zakaria and Shelan, Mohamed and Zilli, Thomas and Carroll, Peter and Roach, Mack},
  title = {Delayed definitive management of localized prostate cancer: what do we know?},
  journal = {Prostate Cancer and Prostatic Diseases},
  year = {2025},
  doi = {10.1038/s41391-024-00876-2}
}
Kostenlos starten →